Showing results (811-820 of 1,602) with videos related to

Sort By:
Pageof 161
RSC Medicinal Chemistry|November 17, 2025
2-Oxoindolin-thiazoline hybrids as scaffold-based therapeutics for T2DM-associated cognitive impairment: design, synthesis, in vitro and in silico studiesWesam S Qayed, Mostafa A Hassan, Halil Şenol, et al.
RSC Medicinal Chemistry|November 3, 2025
Water-soluble cationic porphyrins with enhanced phototoxicity to cancer cell lines for G4-targeting photodynamic therapyÇetin Çelik, Naoko Kakusho, Tianyu Xu, et al.
RSC Medicinal Chemistry|November 3, 2025
Synthesis of novel SRPK1-targeting hybrid compounds incorporating antimetabolites for cancer therapyGeorge Leonidis, Ioanna Sigala, Michail Spathakis, et al.
RSC Medicinal Chemistry|October 9, 2025
Analysis of two screens reveals a correlation between antiamoebic and anti-tubulin activities of phenothiazine and triphenylethylene derivativesOleg Mediannikov, Philipp O Tsvetkov
RSC Medicinal Chemistry|October 16, 2025
Development of small molecule inhibitors of ECM collagen secretionRoss S Mancini, Pierre-Antoine Bissey, Leonardo Massignan, et al.
RSC Medicinal Chemistry|October 13, 2025
Design, synthesis, and antifungal activity of novel amide imidazole CYP51 inhibitors with aromatic fused ring hydrophobic side chainsZixuan Gao, Wenzhan Hao, Jinming Liu, et al.
RSC Medicinal Chemistry|October 6, 2025
Development of novel alpha 2B adrenergic receptor ligands by using a palladium catalyzed Buchwald Hartwig amination with a brominated benzodiazepineMaya R T Fernando, Alexander B Vincent, Shaun G Harrington, et al.
RSC Medicinal Chemistry|September 26, 2025
How to spare gut microbiota from antibiotic effects? PK-PD based innovative strategies, target specificity, and molecule-to-medicinal propertiesAbhishek Rai, Vaishnavi Newaskar, Nibedita Roy, et al.
RSC Medicinal Chemistry|September 29, 2025
Analysis of long-term TNF-alpha induced EGFR tyrosine kinase inhibitor resistance in chordomaHaoShuai Tang, QingRun Zhu, JinHong Fan, et al.
RSC Medicinal Chemistry|September 24, 2025
Design, synthesis, and structure-activity relationship studies of 4-substituted phenylpyrazolidinone derivatives as potent Ku70/80 targeted DNA-PK inhibitorsNarva Deshwar Kushwaha, Pamela VanderVere-Carozza, Tyler L Vernon, et al.
Pageof 161